Moderators: E.J. Cornford, Nottingham/UK; R. Schulz-Wendtland, Erlangen/DE
Update on interval cancers    
S. Weigel, Münster/DE
Personalised screening, when will we be there?
I. Trop, Montréal/CA
Reducing overtreatment: What should follow LORIS?
M. Wallis, Cambridge/UK
How to survive in a hostile environment
E. Morris, New York/US
Discussion

detailed information will be provided soon

Moderators: F. Sardanelli, Milan/IT; G. Forrai, Budapest/HU
Radiological-pathological correlation in 2017
T. Tot, Falun/SE

Moderators: J. Camps Herrero, Alzira/ES; I. Thomassin-Naggara, Paris/FR
Breast radiology in Canada and its contribution to the screening programme
J.M. Seely, Ottawa/CA

Moderators: A. Evans, Dundee/UK; I. Schreer, Hamburg/DE
U. Bick, Berlin/DE
K. Kinkel, Chêne-Bougeries/CH

detailed information will be provided soon

Moderators: U. Bick, Berlin/DE; R.M. Mann, Nijmegen/NL
Summary of submitted awarded posters
E.M. Fallenberg, Berlin/DE
Preoperative Axillary Staging in Breast-Cancer Patients in Post-ACOSOG Z0011 era: Ultrasound and Fine-Needle Aspiration Cytology Accurately Select Patients For Axillary Clearance
A. Bekhouche, Paris/FR
Diffusion Weighted Imaging in breast imaging: a systematic comparison of two different techniques
F. Leone, Milan/IT
Synthetic 2D Mammography Substitutes Digital Mammography as Adjunct to Digital Breast Tomosynthesis: Experience with a Wide-angle Tomosynthesis System
P. Clauser, Vienna/AT

Moderators: M.F. Reiser, Munich/DE; G. Forrai, Budapest/HU
Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size
E. Fallenberg, Berlin/DE

detailed information will be provided soon

Moderators: F.J. Gilbert, Cambridge/UK; P. Panizza, Milan/IT
Abbreviated MRI
C. Kuhl, Aachen/DE
Clinical applications of DWIBS, DKI, DTI, IVIM
P. Baltzer, Vienna/AT
Preoperative: Data on 2,500 patients from the MIPA study
F. Sardanelli, Milan/IT
Comparing MRI and DBT for local staging of breast cancer
F. Pediconi, Rome/IT
Discussion

Moderators: R.M. Pijnappel, Utrecht/NL; U. Bick, Berlin/DE
New risk genes: From research to clinical practice
A. Meindl, Munich/DE
Protocols in high risk screening and follow up
F.J. Gilbert, Cambridge/UK
Phenotype-genotype correlation in mutation and non-mutation carriers
C. Van Ongeval, Leuven/BE
Screening the intermediate risk: Results from a multicenter RCT on MRI versus mammography/US (the MRIB study)
R.M. Trimboli, Milan/IT
Discussion

detailed information will be provided soon

Moderators: G. Forrai, Budapest/HU, T.H. Helbich, Vienna/AT
Hallmarks of cancer
D. Hanahan, Lausanne/CH

Moderators: M. Fuchsjäger, Graz/AT; M.P. Müller-Schimpfle, Frankfurt am Main/DE
…reconstructive procedures in breast
C. Heitmann, Munich/DE
…news of systemic treatment
D. Lüftner, Berlin/DE
…news of pathological markers
C. Denkert, Berlin/DE
…news on management of the axilla
B. Gerber, Rostock/DE
Discussion

Moderators: G. Forrai, Budapest/HU; F. Pediconi, Rome/IT
Update on breast MR background parenchymal enhancement
W.B. DeMartini, Stanford/US

detailed information will be provided soon

Moderators: B. Brkljacic, Zagreb/HR; C. Van Ongeval, Leuven/BE
BC biology and tracer development
M. Herranz, Santiago de Compostela/ES
Multimodality assessment of breast cancer
R.M. Mann, Nijmegen/NL
Quantitative imaging biomarkers
J. Camps Herrero, Alzira/ES
Radiomics, imaging of BC subtypes and heterogeneity
K. Pinker-Domenig, New York/US
Discussion

detailed information will be provided soon

Moderator: M. Fuchsjäger, Graz/AT
Germany against the rest of Europe

Eligibility
Eligible studies focus on breast imaging in a broad sense. Topics may range from early development of new imaging modalities to the clinical role of established imaging modalities in breast care and epidemiological evaluation.

Abstract structure
Abstracts should be no longer than 300 words and be structured as follows:

• Title
  Provide an attractive and concise title for your work
• Purpose
  Clearly describe what you intend to evaluate
• Methods
  Accurately describe the essential methods employed in your research to a level that would allow repetition of the experiment
• Results
  Report the obtained results in a straightforward manner. Please provide confidence intervals and measures of statistical significance when appropriate
• Conclusion
  Place the results in perspective to the purpose of your study

Summary statement
A summary statement of at most 30 words should also be provided, this should allow readers to understand the topic of the study and the most essential findings

Rating
All abstracts will be peer reviewed by at least 2 independent reviewers. Abstracts will be scored on scientific merits, relevance to the EUSOBI audience, originality, and clarity of presentation. Abstracts scored as poor on any of these items will be automatically rejected.

The following scoring system will be used:
1 = Excellent
2 = Good
3 = Moderate
4 = Fair
5 = Poor

Presentation
Accepted abstracts will be presented as traditional posters during the conference. The presenting author must be present at the meeting. The title and summary statement of accepted posters will be listed in the meeting programme. A timeslot of 30 minutes will be assigned to each poster during which the presenting author should be available at the poster location to discuss the findings with interested meeting participants.

Poster award
The highest rated abstracts will receive a certificate of merit and compete for the EUSOBI poster award. If you qualify you will be notified in advance. The prize, a certificate of recognition and free registration to the EUSOBI Annual Scientific Meeting 2018, will be awarded on the final day of the conference.

This initiative is aimed at MD and committed residents in radiology/nuclear medicine (during their 1st or 2nd year of residency) with an interest in breast imaging and with a breast related research project (e.g. graduation thesis, doctor thesis or similar).

During the EUSOBI Annual Scientific Meeting 2017 in Berlin, Germany, the society will offer 1 MD/resident the possibility to orally present his/her breast related thesis in the plenary lecture hall of the EUSOBI Annual Scientific Meeting.

Please note that the application to the MD/Young Resident Initiative requires also a letter of declaration and support from your supervisor.

Grant
EUSOBI is happy to cover the registration fee for the young doctor and will reimburse 2 nights of hotel accommodation up to a maximum amount of € 500,00.

Qualification criteria of the applicant

• To be a MD or a resident in radiology/nuclear medicine in the first 2 years of residency
• To be younger than 30 years at the date of the submission deadline
• To be the first author of the submitted abstract and thesis/research report
• To have submitted a signed letter of support from your supervisor (see below)

Qualification criteria of the abstract

• The abstract should summarize the results of the research, focussing on the main research question and the findings. Only thesis presented for graduation between January 2016 and April 2017 will be accepted.
• The abstract needs to be submitted by the first author

Abstract structure
Abstracts should be no longer than 300 words and be structured as follows:

• Title
  Provide an attractive and concise title for your work.
• Purpose
  Clearly describe what you intend to evaluate.
• Methods
  Accurately describe the essential methods employed in your research to a level that would allow repetition of the experiment.
• Results
  Report the obtained results in a straightforward manner. Please provide confidence intervals and measures of statistical significance when appropriate.
• Conclusion
  Place the results in perspective to the purpose of your study.

Summary statement
A summary statement of at most 30 words should also be provided, this should allow readers to understand the topic of the study and the most essential findings.

Rating
All abstracts will be peer reviewed by at least 2 independent reviewers. Abstracts will be scored on scientific merits, relevance to the EUSOBI audience, originality, and clarity of presentation.

The following scoring system will be used:
1 = Excellent
2 = Good
3 = Moderate
4 = Fair
5 = Poor

Signed declaration and letter of support from the supervisor
All abstracts/theses that are competing for the MD/Young Resident Initiative Grant need to be accompanied by a letter of support from the supervisor. The supervisor needs to be a member of the EUSOBI in good standing.
The declaration must make clear that the application criteria is met and the research has been conducted.

The young physician-scientist grant aims to stimulate residents and young radiologists/nuclear medicine physicians to pursue a career in breast imaging research.

During the EUSOBI Annual Scientific Meeting 2017 in Berlin, Germany, the society will offer 1 young physician (radiology or nuclear medicine) the possibility to orally present his/her breast related research in the plenary lecture hall of the EUSOBI annual scientific meeting.

Please note that this requires also a letter of declaration and support from your head of department.

Grant
EUSOBI is happy to cover the registration fee for the resident/young radiologist or nuclear medicine specialist and will reimburse 2 nights of hotel accommodation up to a maximum amount of € 500,00.

Qualification criteria of the applicant

• To be a resident or young radiologist/nuclear medicine physician
• To be younger than 36 years at the date of the submission deadline
• To be a member of the EUSOBI in good standing
• To be the first author of the submitted abstract
• To have submitted a signed letter of support from your head of department (see below)

Qualification criteria of the abstract

• The abstract should neither be published/presented at another meeting, nor refer to an already published article (print and online), prior to September 2017.
• The abstract needs to be submitted by the first author

Abstract structure
Abstracts should be no longer than 300 words and be structured as follows:

• Title
  Provide an attractive and concise title for your work.
• Purpose
  Clearly describe what you intend to evaluate.
• Methods
  Accurately describe the essential methods employed in your research to a level that would allow repetition of the experiment.
• Results
  Report the obtained results in a straightforward manner. Please provide confidence intervals and measures of statistical significance when appropriate.
• Conclusion
  Place the results in perspective to the purpose of your study.

Summary statement
A summary statement of at most 30 words should also be provided, this should allow readers to understand the topic of the study and the most essential findings.

Rating
All abstracts will be peer reviewed by at least 2 independent reviewers. Abstracts will be scored on scientific merits, relevance to the EUSOBI audience, originality, and clarity of presentation. Abstracts scored as poor on any of these items will be automatically rejected. All other abstracts that are not selected for the grant will still be considered for poster presentation.

The following scoring system will be used:
1 = Excellent
2 = Good
3 = Moderate
4 = Fair
5 = Poor

Signed declaration and letter of support from the supervisor
All abstracts that are competing for the Young Physician-Scientist Grant need to be accompanied by a signed declaration from the head of department. The declaration must make clear that the application criteria is met and the research has been conducted.

This EUSOBI initiative, in the name of our beloved Prof. Carla Boetes means to honour young radiologists or nuclear medicine specialists that have made a significant contribution to breast imaging research.

During the EUSOBI Annual Scientific Meeting 2017 in Berlin, Germany, the society will offer 1 radiologist or nuclear medicine specialist under 40 the possibility to orally present his/her recent breast related work in the plenary lecture hall of the EUSOBI Annual Scientific Meeting and receive the prestigious Carla Boetes Award.

An extended abstract (1000 words, excluding references) on recent results from a research project, which has not yet been published in journals is required.

Award
EUSOBI is happy to cover the registration fee for the Carla Boetes Awardee and will present him/her with a grant of € 2.000,00.

Qualification criteria of the applicant

• To be a certified radiologist or nuclear physician (certification required) radiologist/nuclear medicine physician
• To be younger than 40 years at the date of the submission deadline (copy of passport/identity card required)
• To be a member of the EUSOBI in good standing
• To have published at least three breast imaging related papers in English in a peer-reviewed journal as first author
• To be the first author of the submitted extended abstract
• To have submitted your signed CV with detailed information about your career (including medical graduation, post-graduation certificated, PhD, etc.), involvement in clinical and/or screening breast imaging, and engagement in breast imaging research; please add a complete list of publications in peer reviewed journals

Qualification criteria of the abstract

• The abstract should neither be published/presented at another meeting, nor be an already published article (print and online), prior to September 2017
• The first author of the abstract needs to be the applicant

Abstract structure
Abstracts should be no longer than 1000 words, excluding title and references, and be structured as follows:

• Title
  Provide an attractive and concise title for your work
• Background
  Clearly describe the scientific and clinical problem you have focused your research on
• Methods
  Briefly describe the different steps that you have taken to tackle the scientific/clinical problem
• Results
  Report the obtained results in a straightforward manner
• Clinical Relevance
  Discuss why your results have had a significant effect on breast care, and how this changes practice
• Future Work
  Explain the remaining problems, and the future work you intend to undertake to tackle these issues
• References
• Co-authors

Rating
All abstracts will be peer reviewed by at least 2 independent reviewers. Abstracts will be scored on scientific merits, relevance to the EUSOBI audience, originality, and clarity of presentation. Abstracts scored as poor on any of these items will be automatically rejected. All other abstracts that are not selected for the grant will still be considered for poster presentation.

The following scoring system will be used:
1 = Excellent
2 = Good
3 = Moderate
4 = Fair
5 = Poor

Submission
The extended abstract, copy of certification, copy of passport, and signed CV should be uploaded to the digital abstract submission system: https://esociety.netkey.at/eusobi/abstractsubmission/

Bard
Bayer
Bracco
Fujifilm
GE Healthcare
Guerbet
Hitachi
Hologic
iCAD
Kubtec
MammoRisk
Mammotome
Philips
ScreenPoint
Sectra
Seno Medical
Siemens
Volpara Solutions

Akrus
Bard
Bracco
CMR Naviscan
Daax
Fujifilm
GE Healthcare
Guerbet
Hologic
Koning
Kubtec
LCI
Mammotome
Philips
Seno Medical
Siemens
Thieme
Volpara Solutions

Bard
Bayer
Biopsy Sciences
Bracco
CMR Naviscan
Elswood
Fujifilm
GE Healthcare
Giotto
Guerbet
Hologic
Interact Medical
Klinipath
Kubtec
LCI
Mammotome
Philips
Siemens
Tromp Medical
Teleconsult Europe
Visus
Volpara Solutions

Bard
Bayer
Biopsy Sciences
Bracco
GE Healthcare
Giotto
Guerbet
Hologic
Kubtec
Mammotome
Philips
Siemens
Volpara Solutions

Bard
Bayer
Bracco
CapeRay
Elswood
Gammamedica
GE Healthcare
Guerbet
Hologic
Ire
Koning
Léleman
Mammotome
Naviscan
Philips
Siemens
Volpara Solutions
VuComp